- Home
- HBIO vs RLYB Comparison
HBIO vs RLYB Comparison
Compare HBIO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- RLYB
- Stock Information
- Founded
- HBIO 1901
- RLYB 2018
- Country
- HBIO United States
- RLYB United States
- Employees
- HBIO N/A
- RLYB N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- RLYB Health Care
- Exchange
- HBIO Nasdaq
- RLYB Nasdaq
- Market Cap
- HBIO 24.6M
- RLYB 24.1M
- IPO Year
- HBIO 2000
- RLYB 2021
- Fundamental
- Price
- HBIO $0.52
- RLYB $0.70
- Analyst Decision
- HBIO Buy
- RLYB Hold
- Analyst Count
- HBIO 3
- RLYB 2
- Target Price
- HBIO $2.50
- RLYB N/A
- AVG Volume (30 Days)
- HBIO 17.4M
- RLYB 267.0K
- Earning Date
- HBIO 11-06-2025
- RLYB 11-07-2025
- Dividend Yield
- HBIO N/A
- RLYB N/A
- EPS Growth
- HBIO N/A
- RLYB N/A
- EPS
- HBIO N/A
- RLYB N/A
- Revenue
- HBIO $88,750,000.00
- RLYB $761,000.00
- Revenue This Year
- HBIO N/A
- RLYB N/A
- Revenue Next Year
- HBIO $7.02
- RLYB N/A
- P/E Ratio
- HBIO N/A
- RLYB N/A
- Revenue Growth
- HBIO N/A
- RLYB 154.51
- 52 Week Low
- HBIO $0.28
- RLYB $0.22
- 52 Week High
- HBIO $2.82
- RLYB $1.24
- Technical
- Relative Strength Index (RSI)
- HBIO 58.79
- RLYB 70.45
- Support Level
- HBIO $0.40
- RLYB $0.54
- Resistance Level
- HBIO $0.94
- RLYB $0.72
- Average True Range (ATR)
- HBIO 0.06
- RLYB 0.05
- MACD
- HBIO 0.02
- RLYB 0.01
- Stochastic Oscillator
- HBIO 24.68
- RLYB 89.91
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.